On May 20, 2026, Evogene Ltd EVGN announced its financial results for the first quarter, revealing a significant decline in revenues. The company reported revenues of $300,000, down from $2.3 million during the same period last year. As of March 31, Evogene held approximately $13.1 million in cash and equivalents, with a cash expenditure of about $2.8 million for the quarter.
- Market cap of approximately $8.49 million, indicating a small-cap company.
- GF Scoreā¢: 48/100, suggesting a moderate level of overall performance.
- Financial Strength: Rated 2/10, indicating poor financial health.
What's Behind the News?
The financial results released by Evogene highlight a challenging quarter for the company, which has undergone a strategic pivot since 2025. Ofer Haviv, the President and CEO, emphasized the company's focus on enhancing its technological platform for small-molecule discovery, known as ChemPass AI. This initiative aims to expand Evogene's pharmaceutical and agricultural product offerings through both partnerships and internal projects. The collaboration with Google Cloud announced in February 2026 is expected to integrate advanced AI tools to improve dataset generation, thereby enhancing the efficiency of small-molecule discovery and optimization.
Evogene Ltd operates within the biotechnology sector, focusing on computational biology to revolutionize product development for life-science industries, including human health and agriculture. With a market capitalization of approximately $8.49 million, Evogene is classified as a small-cap company. The company utilizes its proprietary Computational Predictive Biology (CPB) platform to develop products based on microbes, small molecules, and genetic elements.
How Is EVGN Valued?
Currently, GF Valueā¢ data is not available for Evogene. The company's P/E ratio is not applicable, as it has reported negative earnings. However, the price-to-sales (P/S) ratio stands at 1.42, indicating that the stock is trading at a relatively low valuation compared to its sales. Investors should consider this context when evaluating the stock's attractiveness. For more detailed information, visit the EVGN stock page.
What Does EVGN's GF Scoreā¢ Tell Us?
The GF Scoreā¢ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Scoreā¢ values have been found to generate higher long-term returns (backtested 2006-2021).
| Metric | Rating |
|---|---|
| GF Scoreā¢ | 48 |
| Financial Strength | 2/10 |
| Profitability | 2/10 |
| Growth | 4/10 |
Evogene's GF Scoreā¢ of 48 indicates a moderate performance level, but its low ratings in Financial Strength and Profitability (both at 2/10) suggest significant challenges in these areas. The Growth rank of 4/10 indicates some potential for improvement, but overall, the company faces considerable hurdles. For further insights, visit the EVGN stock page.
What Are Insiders Doing with EVGN Stock?
There has been no insider buying or selling activity reported in the last three months, indicating a lack of confidence or interest from insiders in trading their shares at this time.
What This Means for Investors
Given the current financial metrics and the strategic direction of Evogene, investors should exercise caution. The company's low GF Scoreā¢, particularly in Financial Strength and Profitability, coupled with a significant revenue decline, raises concerns about its future viability. For the complete analysis, visit the EVGN stock page. You can also use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is EVGN's GF Scoreā¢?
EVGN's GF Scoreā¢ is 48/100, indicating a moderate level of overall performance based on multiple financial metrics.
How is EVGN valued?
Evogene's price-to-sales (P/S) ratio is 1.42, suggesting that the stock is trading at a relatively low valuation compared to its sales.
What is EVGN's P/E ratio compared to historical?
Evogene does not have a P/E ratio available due to negative earnings, which raises concerns about its financial strength and operational performance.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
